Michael Potter

15.5k total citations · 3 hit papers
284 papers, 12.7k citations indexed

About

Michael Potter is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Hematology. According to data from OpenAlex, Michael Potter has authored 284 papers receiving a total of 12.7k indexed citations (citations by other indexed papers that have themselves been cited), including 154 papers in Molecular Biology, 76 papers in Radiology, Nuclear Medicine and Imaging and 74 papers in Hematology. Recurrent topics in Michael Potter's work include Glycosylation and Glycoproteins Research (74 papers), Monoclonal and Polyclonal Antibodies Research (74 papers) and Multiple Myeloma Research and Treatments (65 papers). Michael Potter is often cited by papers focused on Glycosylation and Glycoproteins Research (74 papers), Monoclonal and Polyclonal Antibodies Research (74 papers) and Multiple Myeloma Research and Treatments (65 papers). Michael Potter collaborates with scholars based in United States, Canada and United Kingdom. Michael Potter's co-authors include Stuart Rudikoff, Rose Lieberman, Thelma B. Dunn, Richard P. Nordan, J S Wax, J. Frederic Mushinski, Eduardo A. Padlan, Ernest S. Simms, Herman N. Eisen and Janet G. Pumphrey and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Michael Potter

280 papers receiving 11.0k citations

Hit Papers

Immunoglobulin-producing tumors and myeloma proteins of m... 1957 2026 1980 2003 1972 1957 1974 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Potter United States 62 6.8k 4.6k 4.0k 2.2k 2.0k 284 12.7k
Ian S. Trowbridge United States 66 8.2k 1.2× 5.4k 1.2× 3.5k 0.9× 1.1k 0.5× 1.6k 0.8× 139 14.5k
Melvyn F. Greaves United Kingdom 65 5.7k 0.8× 7.8k 1.7× 2.9k 0.7× 3.5k 1.6× 2.0k 1.0× 186 17.9k
Daniel J. Capon United States 41 7.6k 1.1× 3.2k 0.7× 1.5k 0.4× 2.0k 0.9× 1.4k 0.7× 60 14.8k
Fritz Melchers Switzerland 77 5.9k 0.9× 14.7k 3.2× 4.6k 1.2× 1.7k 0.8× 2.4k 1.2× 326 20.3k
Steven J. Burakoff United States 71 7.7k 1.1× 9.7k 2.1× 2.4k 0.6× 1.5k 0.7× 3.5k 1.7× 278 17.3k
Jay C. Unkeless United States 49 4.3k 0.6× 5.3k 1.2× 2.6k 0.7× 1.0k 0.5× 1.5k 0.8× 89 11.1k
L A Herzenberg United States 43 4.6k 0.7× 8.2k 1.8× 4.1k 1.0× 621 0.3× 1.5k 0.8× 82 13.6k
Joseph B. Bolen United States 71 6.8k 1.0× 7.8k 1.7× 2.7k 0.7× 1.1k 0.5× 4.1k 2.1× 171 16.0k
Sherie L. Morrison United States 53 6.8k 1.0× 4.4k 1.0× 6.6k 1.6× 706 0.3× 1.7k 0.9× 242 11.4k
Ivan D. Horak United States 62 4.8k 0.7× 5.7k 1.2× 1.8k 0.5× 1.0k 0.5× 3.9k 2.0× 205 14.0k

Countries citing papers authored by Michael Potter

Since Specialization
Citations

This map shows the geographic impact of Michael Potter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Potter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Potter more than expected).

Fields of papers citing papers by Michael Potter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Potter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Potter. The network helps show where Michael Potter may publish in the future.

Co-authorship network of co-authors of Michael Potter

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Potter. A scholar is included among the top collaborators of Michael Potter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Potter. Michael Potter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Potter, Michael, et al.. (2025). Heart Scar-In-A-Dish: Tissue Culture Platform to Study Myocardial Injury and Mechanics In Vitro. Journal of Biomechanical Engineering. 148(2).
2.
Potter, Michael, et al.. (2023). Bayesian Weapon System Reliability Modeling with Cox-Weibull Neural Network. 1–6. 1 indexed citations
3.
Potter, Michael & William J. Richardson. (2021). Fabrication and characterization methods for investigating cell-matrix interactions in environments possessing spatial orientation heterogeneity. Acta Biomaterialia. 136. 420–428. 1 indexed citations
4.
Potter, Michael. (2008). Mineral resource of the month: vermiculite. 53(3). 20–21. 1 indexed citations
5.
Takizawa, Makiko, Zhiyu Li, Wendy Dubois, et al.. (2008). AID expression levels determine the extent of cMyc oncogenic translocations and the incidence of B cell tumor development. The Journal of Experimental Medicine. 205(9). 1949–1957. 108 indexed citations
6.
Potter, Michael. (2007). The Early History of Plasma Cell Tumors in Mice, 1954–1976†. Advances in cancer research. 98. 17–51. 12 indexed citations
7.
Chattopadhyay, Gouri, Abdul Qayyum Khan, Goutam Sen, et al.. (2007). Transgenic Expression of Bcl-xL or Bcl-2 by Murine B Cells Enhances the In Vivo Antipolysaccharide, but Not Antiprotein, Response to Intact Streptococcus pneumoniae. The Journal of Immunology. 179(11). 7523–7534. 25 indexed citations
8.
Park, Sung Sup, Arthur L. Shaffer, Joong Su Kim, et al.. (2005). Insertion of Myc into Igh Accelerates Peritoneal Plasmacytomas in Mice. Cancer Research. 65(17). 7644–7652. 19 indexed citations
9.
Manuel, Rohini, et al.. (1998). Adjuvant use of GM-CSF in invasive aspergillosis.. UCL Discovery (University College London). 2 indexed citations
10.
Largaespada, David A., et al.. (1992). A retrovirus that expresses v-abl and c-myc oncogenes rapidly induces plasmacytomas.. PubMed. 7(4). 811–9. 31 indexed citations
11.
Troppmair, Jakob, Michael Potter, J S Wax, & U R Rapp. (1989). An altered v-raf is required in addition to v-myc in J3V1 virus for acceleration of murine plasmacytomagenesis.. Proceedings of the National Academy of Sciences. 86(24). 9941–9945. 27 indexed citations
12.
Duncan, Robert, et al.. (1988). Genes That Modify Expression of Major Urinary Proteins in Mice. Molecular and Cellular Biology. 8(7). 2705–2712. 14 indexed citations
13.
Potter, Michael, J W Hartley, J S Wax, & Daniel Gallahan. (1984). Effect of MuLV-related genes on plasmacytomagenesis in BALB/c mice.. The Journal of Experimental Medicine. 160(2). 435–440. 26 indexed citations
14.
Lieberman, R, Lawrence A. D'Hoostelaere, William Humphrey, Susumu Nishinarita, & Michael Potter. (1983). An allotype linked gene that is associated with a negative or very low anti-phosphorylcholine response (PC) phenotype in wild mice (CNV).. The Journal of Immunology. 131(3). 1570–1575. 3 indexed citations
15.
Callahan, Robert, William N. Drohan, Daniel Gallahan, Lawrence A. D'Hoostelaere, & Michael Potter. (1982). Novel class of mouse mammary tumor virus-related DNA sequences found in all species of Mus, including mice lacking the virus proviral genome.. Proceedings of the National Academy of Sciences. 79(13). 4113–4117. 61 indexed citations
16.
Wiener, Francis, Magda Babonits, Jack Spira, George Klein, & Michael Potter. (1980). Cytogenetic studies on IgA/lambda-producing murine plasmacytomas: Regular occurrence of a T(12;15) translocation. Somatic Cell and Molecular Genetics. 6(6). 731–738. 34 indexed citations
17.
Claflin, J L, Stuart Rudikoff, Michael Potter, & Joseph M. Davie. (1975). Structural, functional, and idiotypic characteristics of a phosphorylcholine-binding IgA myeloma protein of C57BL/ka allotype.. The Journal of Experimental Medicine. 141(3). 608–619. 18 indexed citations
18.
Lieberman, R, Michael Potter, E. B. Mushinski, William Humphrey, & Stuart Rudikoff. (1974). GENETICS OF A NEW IgVH (T15 IDIOTYPE) MARKER IN THE MOUSE REGULATING NATURAL ANTIBODY TO PHOSPHORYLCHOLINE. The Journal of Experimental Medicine. 139(4). 983–1001. 206 indexed citations
19.
Potter, Michael. (1971). Plasma cell tumour-formation and antigen-binding myeloma proteins in mice.. BMJ. 2(5757). 320.1–320. 1 indexed citations
20.
Potter, Michael. (1968). A resumé of the current status of the development of plasma-cell tumors in mice.. PubMed. 28(9). 1891–6. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026